Bluejay Operating Income from 2010 to 2024
| BJDX Stock | USD 4.10 0.74 15.29% |
Operating Income | First Reported 2010-12-31 | Previous Quarter -10.3 M | Current Value -9.8 M | Quarterly Volatility 3.4 M |
Check Bluejay Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bluejay Diagnostics' main balance sheet or income statement drivers, such as Net Interest Income of 173.1 K, Depreciation And Amortization of 820 K or Interest Expense of 22.8 K, as well as many indicators such as Price To Sales Ratio of 1.2 K, Dividend Yield of 0.0 or PTB Ratio of 24.26. Bluejay financial statements analysis is a perfect complement when working with Bluejay Diagnostics Valuation or Volatility modules.
Bluejay | Operating Income |
Latest Bluejay Diagnostics' Operating Income Growth Pattern
Below is the plot of the Operating Income of Bluejay Diagnostics over the last few years. Operating Income is the amount of profit realized from Bluejay Diagnostics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Bluejay Diagnostics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Bluejay Diagnostics' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bluejay Diagnostics' overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Bluejay Operating Income Regression Statistics
| Arithmetic Mean | (3,344,355) | |
| Coefficient Of Variation | (101.02) | |
| Mean Deviation | 2,585,544 | |
| Median | (1,631,413) | |
| Standard Deviation | 3,378,574 | |
| Sample Variance | 11.4T | |
| Range | 9.1M | |
| R-Value | (0.72) | |
| Mean Square Error | 5.9T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | (545,537) | |
| Total Sum of Squares | 159.8T |
Bluejay Operating Income History
About Bluejay Diagnostics Financial Statements
Bluejay Diagnostics investors use historical fundamental indicators, such as Bluejay Diagnostics' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bluejay Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Income | -10.3 M | -9.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bluejay Stock Analysis
When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.